The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Open accessPublished version of a preprint
Abstract
A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes coronavirus disease 2019 (COVID-19) and has been rapidly spreading around the globe 1,2. SARS-CoV-2 shows some similarities to other coronaviruses; however, treatment options and an understanding of how SARS-CoV-2 infects cells are lacking. Here we identify the host cell pathways that are modulated by SARS-CoV-2 and show that inhibition of these pathways prevents viral replication in human cells. We established a human cell-culture model for infection with a clinical isolate of SARS-CoV-2. Using this cell-culture system, we determined the infection profile of SARS-CoV-2 by translatome 3 and proteome proteomics at different times after infection. These analyses revealed that SARS-CoV-2 reshapes central cellular pathways such as translation, splicing, carbon metabolism, protein homeostasis (proteostasis) and nucleic acid metabolism. Small-molecule inhibitors that target these pathways prevented viral replication in cells. Our results reveal the cellular infection profile of SARS-CoV-2 and have enabled the identification of drugs that inhibit viral replication. We anticipate that our results will guide efforts to understand the molecular mechanisms that underlie the modulation of host cells after infection with SARS-CoV-2. Furthermore, our findings provide insights for the development of therapies for the treatment of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical isolate infection models have been developed using Caco-2 cells154 with temporal proteome changes identified during infection using multiplexed MS by combining metabolic labelling with tandem mass tagging methods.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [154]
In the citing paper
“Building on this knowledge of coronavirus infection, recent proteomics studies have focused on SARS-CoV-2, uncovering additional potential therapeutic targets154,155.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Data Structures for Statistical Computing in Python
McKinney, W. (2010) · Proceedings of the Python in Science Conferences · doi:10.25080/majora-92bf1922-00a · Cited by 12,930
The NumPy Array: A Structure for Efficient Numerical Computation
van der Walt, S., Colbert, S. C., & Varoquaux, G. (2011) · Computing in Science & Engineering · doi:10.1109/mcse.2011.37 · Cited by 9,381
The Perseus computational platform for comprehensive analysis of (prote)omics data
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 8,803
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876
Cited by
Sorted by citations
Items 301–400 of 998
Recent advances in small-molecular therapeutics for COVID-19
Zhong, L., Zhao, Z., Peng, X., Zou, J., & Yang, S. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac024 · Cited by 29
Valyaeva, A. A., Zharikova, A. A., & Sheval, E. V. (2022) · Cell Biology International · doi:10.1002/cbin.11928 · Cited by 30
Host mitochondria: more than an organelle in SARS-CoV-2 infection
Shoraka, S., Samarasinghe, A. E., Ghaemi, A., & Mohebbi, S. R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1228275 · Cited by 29
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity
Stewart, H., Lu, Y., O’Keefe, S. M., Valpadashi, A., Cruz‐Zaragoza, L. D., Michel, H. A., Nguyen, S. K., Carnell, G., Lukhovitskaya, N. I., Milligan, R., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108080 · Cited by 28
Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2
Bleasel, M. D., & Peterson, G. M. (2020) · Pharmaceuticals · doi:10.3390/ph13120428 · Cited by 29
Tugaeva, K. V., Sysoev, A. A., Kapitonova, A. A., Smith, J. L. R., Zhu, P., Cooley, R. B., Antson, A. A., & Sluchanko, N. N. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167891 · Cited by 27
Schweizer, L., Schaller, T., Zwiebel, M., Karayel, Ö., Müller, J., Zeng, W., Dintner, S., Nordmann, T. M., Hirschbühl, K., Märkl, B., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317459 · Cited by 26
Moon, S., Han, S., Jang, I.-H., Ryu, J., Rha, M.-S., Cho, H., Yoon, S. S., Nam, K. T., Kim, C., Park, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47963-5 · Cited by 27
Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
Qiu, Q., Huang, Y., Liu, X., Huang, F., Li, X., Cui, L., Luo, H., & Luo, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.570893 · Cited by 26
Zhou, L., Huntington, K. E., Zhang, S., Carlsen, L., So, E. Y., Parker, C., Şahin, İ., Safran, H. P., Kamle, S., Lee, C.-M., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27799 · Cited by 26
Progress and pitfalls of a year of drug repurposing screens against COVID-19
Sourimant, J., Aggarwal, M., & Plemper, R. K. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.06.004 · Cited by 26
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
Belinchón, F. J. Z., Moeller, R. A., Laßwitz, L., van Ham, M., Becker, M., Brogden, G., Rosendal, E., Bi, W., Carriquí-Madroñal, B., Islam, K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103469 · Cited by 25
Lee, S. R., ROH, J., Ryu, J., Shin, H., & Hong, E. (2022) · Cell & Bioscience · doi:10.1186/s13578-021-00740-z · Cited by 27
Gelhausen, R., Müller, T., Svensson, S. L., Alkhnbashi, O. S., Sharma, C. M., Eggenhofer, F., & Backofen, R. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab549 · Cited by 22
Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater
Wilhelm, A., Agrawal, S., Schoth, J., Meinert‐Berning, C., Bastian, D., Orschler, L., Ciesek, S., Teichgräber, B., Wintgens, T., Lackner, S., et al. (2022) · Viruses · doi:10.3390/v14091876 · Cited by 25
Self-citationNucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells
Merino, V. F., Yan, Y., Ordoñez, A. A., Bullen, C. K., Lee, A. H., Saeki, H., Ray, K., Huang, T., Jain, S. K., & Pomper, M. G. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105550 · Cited by 26
A catabolic state in a kidney transplant recipient with COVID‐19
Billah, M., Santeusanio, A. D., Delaney, V. B., Cravedi, P., & Farouk, S. S. (2020) · Transplant International · doi:10.1111/tri.13635 · Cited by 25
Beys‐da‐Silva, W. O., da Rosa, R. L., Santi, L., Cagnini, E. F. T., Terraciano, P. B., Guimarães, J. A., Passos, E. P., & Berger, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165999 · Cited by 25
Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19
Singh, R., Singh, P. K., Kumar, R., Kabir, M. T., Kamal, M. A., Rauf, A., Albadrani, G. M., Sayed, A. A., Mousa, S. A., Abdel‐Daim, M. M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652335 · Cited by 27
Mesri, E. A., & Lampidis, T. J. (2021) · IUBMB Life · doi:10.1002/iub.2546 · Cited by 24
Sachse, M., Tenorio, R., de Castro, I. F., Muñoz‐Basagoiti, J., Perez‐Zsolt, D., Regué, D. R., Rodon, J., Losada, A., Avilés, P., Cuevas, C., et al. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105270 · Cited by 25
Compartmentalization and regulation of GTP in control of cellular phenotypes
Wolff, D. W., Bianchi, A., & Nikiforov, M. A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.05.012 · Cited by 25
Tumurkhuu, G., Casanova, N. G., Kempf, C. L., Laguna, D. E., Camp, S. M., Dagvadorj, J., Song, J. H., Hernon, V. R., Travelli, C., Montano, E. N., et al. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100181 · Cited by 27
Zheng, W., Yan, L., Gou, C., Zhang, Z., Zhang, J. J., Hu, M., & Wang, F. (2021) · International Journal of Intelligent Systems · doi:10.1002/int.22449 · Cited by 23
Inhibiting the reproduction of SARS-CoV-2 through perturbations in human lung cell metabolic network
Delattre, H., Sasidharan, K., & Soyer, O. S. (2020) · Life Science Alliance · doi:10.26508/lsa.202000869 · Cited by 24
Roles of existing drug and drug targets for COVID-19 management
Ayele, A. G., Enyew, E. F., & Kifle, Z. D. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100103 · Cited by 24
Establishment of human distal lung organoids for SARS-CoV-2 infection
Wang, T., Zhang, N., Fan, S., Zhao, L., Song, W., Gong, Y., Shen, Q., Zhang, C., Ren, P., Lin, C., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00346-2 · Cited by 24
Umar, S., Palasiewicz, K., Meyer, A., Kumar, P., Prabhakar, B. S., Volin, M. V., Rahat, R., Al‐Awqati, M., Chang, H. J., Zomorrodi, R. K., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04329-8 · Cited by 24
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Mancini, M., Natoli, S., Gardoni, F., Luca, M. D., & Pisani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065618 · Cited by 24
Computational Immune Proteomics Approach to Target COVID-19
Tilocca, B., Britti, D., Urbani, A., & Roncada, P. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00553 · Cited by 24
Potential antiviral options against SARS-CoV-2 infectionPreprint
Ianevski, A., Yao, R., Fenstad, M. H., Biza, S., Zusinaite, E., Reisberg, T., Lysvand, H., Løseth, K., Landsem, V. M., Malmring, J. F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.12.091165 · Cited by 25
Zhou, X., Zhou, L., Ge, X., Guo, X., Han, J., Zhang, Y., & Yang, H. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00592 · Cited by 23
Kim, D., Lee, J., Bal, J., Seo, S. K., Chong, C., Lee, J. H., & Park, H. (2021) · Viruses · doi:10.3390/v13050796 · Cited by 23
Panagiotopoulos, A. A., Tseliou, M., Karakasiliοtis, I., Kotzampasi, D. M., Daskalakis, V., Kesesidis, N., Notas, G., Lionis, C. D., Kampa, M., Pirintsos, S., et al. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.798 · Cited by 24
Thieulent, C., Dittmar, W., Balasuriya, U. B. R., Crossland, N. A., Wen, X., Richt, J. A., & Carossino, M. (2023) · mSphere · doi:10.1128/msphere.00558-22 · Cited by 22
COVID-19: The Effect of Host Genetic Variations on Host–Virus Interactions
Chakravarty, S. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00637 · Cited by 23
The Roles of hnRNP Family in the Brain and Brain-Related Disorders
Brandão‐Teles, C., Antunes, A. S. L. M., Vrechi, T. A. D. M., & Martins‐de‐Souza, D. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03747-4 · Cited by 23
Coombs, K. M. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1821656 · Cited by 22
Huggett, J. F., Moran‐Gilad, J., & Lee, J. E. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000768 · Cited by 22
Willforss, J., Siino, V., & Levander, F. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04043-5 · Cited by 21
Science's Response to CoVID‐19
Long, M. J. C., & Aye, Y. (2021) · ChemMedChem · doi:10.1002/cmdc.202100079 · Cited by 22
Applied Proteomics in ‘One Health’
Katsarou, E. I., Billinis, C., Galamatis, D., Fthenakis, G. C., Tsangaris, G. T., & Katsafadou, A. I. (2021) · Proteomes · doi:10.3390/proteomes9030031 · Cited by 24
Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19
Cantwell, A. M., Singh, H., Platt, M. P., Yu, Y., Lin, Y.-H., Ikeno, Y., Hubbard, G. B., Xiang, Y., González-Juarbe, N., & Dube, P. H. (2021) · Journal of Virology · doi:10.1128/jvi.01010-21 · Cited by 22
Rais, Y., Fu, Z., & Drabovich, A. P. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09325-x · Cited by 23
Messina, F., Giombini, E., Montaldo, C., Sharma, A., Piacentini, M., Zoccoli, A., Sékaly, R., Locatelli, F., Zumla, A. I., Maeurer, M. J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03881-8 · Cited by 23
de Souza, G. A. P., Bideau, M. L., Boschi, C., Ferreira, L., Wurtz, N., Devaux, C. A., Colson, P., & Scola, B. L. (2021) · Viruses · doi:10.3390/v14010023 · Cited by 21
Grossegesse, M., Bourquain, D. R., Neumann, M., Schaade, L., Schulze, J., Mache, C., Wolff, T., Nitsche, A., & Doellinger, J. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00783 · Cited by 21
Wang, L., Yin, Z., Puppala, M., Ezeana, C. F., Wong, K., He, T., Gotur, D. B., & Wong, S. T. C. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3139773 · Cited by 22
Dahal, S., Cheng, R., Cheung, P. K., Been, T., Malty, R. H., Geng, M., Manianis, S., Shkreta, L., Jahanshahi, S., Toutant, J., et al. (2021) · Viruses · doi:10.3390/v14010060 · Cited by 22
Translational Control of COVID-19 and Its Therapeutic Implication
Zhang, D., Zhu, L., Wang, Y., Li, P., & Gao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857490 · Cited by 25
Wang, J. Y., Roehrl, M. H. A., Roehrl, V. B., & Roehrl, M. H. A. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100147 · Cited by 23
Cell and Animal Models for SARS-CoV-2 Research
Bestion, E., Halfon, P., Mezouar, S., & Mège, J. (2022) · Viruses · doi:10.3390/v14071507 · Cited by 24
Wilhelm, A., Schoth, J., Meinert‐Berning, C., Agrawal, S., Bastian, D., Orschler, L., Ciesek, S., Teichgräber, B., Wintgens, T., Lackner, S., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.157375 · Cited by 26
Self-citationMulti-OMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells
Pinto, S. M., Subbannayya, Y., Kim, H., Hagen, L., Górna, M. W., Nieminen, A. I., Bjørås, M., Espevik, T., Kainov, D. E., & Kandasamy, R. K. (2022) · iScience · doi:10.1016/j.isci.2022.105895 · Cited by 21
Nuclear translocation of spike mRNA and protein is a novel feature of SARS-CoV-2
Sattar, S., Kabát, J., Jerome, K., Feldmann, F., Bailey, K. L., & Mehedi, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1073789 · Cited by 23
CRISPR‑based diagnostic approaches: Implications for rapid management of future pandemics (Review)
Shariq, M., Khan, M. K., Raj, R., Ahsan, N., Singh, R., & Kumar, P. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13005 · Cited by 25
Clinical efficacy of low-dose emetine for patients with COVID-19: a real-world study
Fan, S., Zhen, Q., Chen, C., Wang, W., Wu, Q., Ma, H., Zhang, C., Zhang, L., Lu, B., Ge, H., et al. (2020) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000076 · Cited by 22
Li, Z., Yao, Y., Cheng, X., Chen, Q., Zhao, W., Ma, S., Li, Z., Zhou, H., Li, W., & Teng, F. (2021) · iScience · doi:10.1016/j.isci.2021.102148 · Cited by 21
Zhong, L. L. D., Zhu, L., & Cai, Z. (2021) · Journal of Analysis and Testing · doi:10.1007/s41664-021-00197-6 · Cited by 22
Alaiya, A. A., Alshukairi, A. N., Shinwari, Z., AL-Fares, M., Alotaibi, J., AlOmaim, W. S., Alsharif, I., Bakheet, R., Alharbi, L., Allam, R., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s322430 · Cited by 20
Application of omics technology to combat the COVID‐19 pandemic
Yang, J., Yan, Y., & Zhong, W. (2021) · MedComm · doi:10.1002/mco2.90 · Cited by 20
Effect of Short Time of SARS-CoV-2 Infection in Caco-2 Cells
Zupin, L., Fontana, F., Clemente, L., Ruscio, M., Ricci, G., & Crovella, S. (2022) · Viruses · doi:10.3390/v14040704 · Cited by 21
Luo, S., Moussa, E. W., López-Orozco, J., Felix-Lopez, A., Ishida, R., Fayad, N., Gomez‐Cardona, E., Wang, H., Wilson, J. A., Kumar, A., et al. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00458 · Cited by 21
Managing Viral Emerging Infectious Diseases via Current and Future Molecular Diagnostics
Altındiş, M., & Kilbaş, E. P. K. (2023) · Diagnostics · doi:10.3390/diagnostics13081421 · Cited by 21
Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19
Huang, C.-T., Chao, T., Kao, H., Pang, Y.-H., Lee, W.-H., Hsieh, C.-H., Chang, S., Huang, H., & Juan, H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05646 · Cited by 20
Endothelial Cell Contributions to COVID-19
Oxford, A. E., Halla, F., Robertson, E. B., & Morrison, B. E. (2020) · Pathogens · doi:10.3390/pathogens9100785 · Cited by 20
Proteomics in the COVID‐19 Battlefield: First Semester Check‐Up
Grenga, L., & Armengaud, J. (2020) · PROTEOMICS · doi:10.1002/pmic.202000198 · Cited by 18
Reducing SARS-CoV-2 pathological protein activity with small molecules
Pluskota‐Karwatka, D., Hoffmann, M., & Barciszewski, J. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.03.012 · Cited by 18
Diagnosis, prevention, and treatment of coronavirus disease: a review
Sarangi, M. K., Padhi, S. K., Dheeman, S., Karn, S. K., Patel, L. D., Yi, D. K., & Nanda, S. S. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1944103 · Cited by 19
Calvet, J., Berenguer, A., Gay, M., Massanella, M., Domingo, P., Llop-Vilaltella, M., Sánchez-Jiménez, E., Arévalo, M., Carrillo, J., Albiñana-Giménez, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04683-w · Cited by 20
de Bruin, N. M. W. J., Schneider, A., Reus, P., Talmon, S., Ciesek, S., Bojková, D., Cinatl, J. J., Lodhi, I., Charlesworth, B. R., Sinclair, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031049 · Cited by 21
Self-citationPost-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19
Qiu, Y., Wu, D., Ning, W., 张建成, Shu, T., Huang, M., Chen, R., Huang, M., Xu, J., Yang, Q., et al. (2021) · National Science Review · doi:10.1093/nsr/nwab143 · Cited by 23
Bojková, D., Reus, P., Panosch, L., Bechtel, M., Rothenburger, T., Kandler, J. D., Pfeiffer, A., Wagner, J. U. G., Shumliakivska, M., Dimmeler, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.105944 · Cited by 20
Self-citationMa, P., Liu, J., Pang, S., Zhou, W., Yu, H., Wang, M., Dong, T., Wang, Y., Wang, Q., & Liu, A. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341300 · Cited by 20
Current Advances in Viral Nanoparticles for Biomedicine
Sun, X., Tian, T., Lian, Y., & Cui, Z. (2024) · ACS Nano · doi:10.1021/acsnano.4c13146 · Cited by 21
Mild anemia as a single independent predictor of mortality in patients with COVID‐19
Tremblay, D. A., Rapp, J. L., Alpert, N., Lieberman‐Cribbin, W., Mascarenhas, J. O., Taioli, E., & Ghaffari, S. (2021) · eJHaem · doi:10.1002/jha2.167 · Cited by 18
SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFsPreprint
Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L., Chen, D.-Y., Bauer, M., Taylor, H. B., Conway, H. L., Tomkins-Tinch, C., Finkel, Y., et al. (2020) · bioRxiv · doi:10.1101/2020.10.02.324145 · Cited by 21
SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathwayPreprint
Chen, D. W., Khan, N., Close, B. J., Goel, R. K., Blum, B. C., Tavares, A. H., Kenney, D., Conway, H. L., Ewoldt, J. K., Kapell, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.27.358259 · Cited by 20
Martínez-Colón, G. J., Ratnasiri, K., Chen, R., Jiang, S., ZANLEY, E. J., Rustagi, A., Verma, R., Chen, H. M., Andrews, J. R., Mertz, K. D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.24.465626 · Cited by 20
Praissman, J. L., & Wells, L. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100103 · Cited by 19
Small Extracellular Vesicles and COVID19—Using the “Trojan Horse” to Tackle the Giant
Borowiec, B. M., Volponi, A. A., Mozdziak, P. E., Kempisty, B., & Dyszkiewicz-Konwińska, M. (2021) · Cells · doi:10.3390/cells10123383 · Cited by 19
Kumar, A., Grams, T. R., Bloom, D. C., & Tóth, Z. (2022) · Viruses · doi:10.3390/v14051039 · Cited by 19
The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets
Ma, J., Deng, Y., Zhang, M., & Yu, J. (2022) · Virulence · doi:10.1080/21505594.2022.2092941 · Cited by 20
Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19
Zhang, J., Zhang, Y., Xia, Y., & Sun, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.034 · Cited by 19
Albarnaz, J. D., Kite, J., Oliveira, M., Li, H., Di, Y., Christensen, M. H., Paulo, J. A., Antrobus, R., Gygi, S. P., Schmidt, F. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43299-8 · Cited by 19
Tushir, S., Kamanna, S., Nath, S. S., Bhat, A., Rose, S., Aithal, A. R., & Tatu, U. S. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00808 · Cited by 19
The Centrality of Obesity in the Course of Severe COVID-19
Liu, D., Zhang, T., Wang, Y., & Xia, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.620566 · Cited by 22
Schultz, B. T., Zaliani, A., Ebeling, C., Reinshagen, J., Bojková, D., Lage‐Rupprecht, V., Karki, R., Lukassen, S., Gadiya, Y., Ravindra, N. G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90296-2 · Cited by 19
Self-citationJing, L., Wu, X., Krist, M. P., Hsiang, T.-Y., Campbell, V. L., McClurkan, C. L., Favors, S. M., Hemingway, L. A., Godornes, C., Tong, D. Q., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.158126 · Cited by 18
Selvaraj, G., Kaliamurthi, S., Peslherbe, G. H., & Wei, D. (2021) · F1000Research · doi:10.12688/f1000research.50850.3 · Cited by 18
SARS-CoV-2 N protein recruits G3BP to double membrane vesicles to promote translation of viral mRNAs
Long, S., Guzyk, M. M., Vidakovics, L. P., Han, X. Y., Sun, R., Wang, M., Panas, M. D., Urgard, E., Coquet, J. M., Merits, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54996-3 · Cited by 18
Selvaraj, G., Kaliamurthi, S., Peslherbe, G. H., & Wei, D. (2021) · F1000Research · doi:10.12688/f1000research.50850.2 · Cited by 18
Yu, S., Li, X., Xin, Z., Sun, L., & Shi, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923387 · Cited by 18
Atlas of interactions between SARS-CoV-2 macromolecules and host proteins
Li, G., Tang, Z., Fan, W., Wang, X., Huang, L., Jia, Y., Wang, M., Hú, Z., & Zhou, Y. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100068 · Cited by 19
Bustamante, S., Yau, Y. Y., Boys, V., Chang, J., Paramsothy, S., Pudipeddi, A. V., Leong, R. W. L., & Wasinger, V. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314776 · Cited by 18
P-Massive: A Real-Time Search Engine for a Multi-Terabyte Mass Spectrometry Database
Batsoyol, N., Pullman, B. S., Wang, M., Bandeira, N., & Swanson, S. (2022) · International Conference for High Performance Computing, Networking, Storage and Analysis (SC) · doi:10.1109/sc41404.2022.00014 · Cited by 18
Testing for SARS-CoV-2: lessons learned and current use cases
Theel, E. S., Kirby, J. E., & Pollock, N. R. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-23 · Cited by 18
Advances in the Clinical Application of High-throughput Proteomics
Cui, M., Deng, F., Disis, M. L., Cheng, C., & Zhang, L. (2024) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2024.00006 · Cited by 18
Rana, R., Rathi, V., & Ganguly, N. K. (2020) · Journal of Proteins and Proteomics · doi:10.1007/s42485-020-00052-9 · Cited by 18
Annulate lamellae and intracellular pathogens
Eymieux, S., Blanchard, E., Uzbekov, R. E., Hourioux, C., & Roingeard, P. (2021) · Cellular Microbiology · doi:10.1111/cmi.13328 · Cited by 18
Metadata
- Authors
- Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C.
- Affiliations
- Goethe University Frankfurt (DE)
- University Hospital Frankfurt (DE)
- Corresponding author
- Cinatl, Jindrich
- Münch, Christian
- ORCID
- Venue
- Nature
- Published
- 2020-05-14
- Volume
- 583
- Issue
- 7816
- Pages
- 469-472
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7616921
- OpenAlex
- W3026002191
- Cited by
- 1,010
- References
- 53
- Citations by year
- 2026: 25 · 2025: 58 · 2024: 86 · 2023: 118 · 2022: 198 · 2021: 347 · 2020: 177
- FWCI
- 27.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- Research Square (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- Frankfurter Stiftung für krebskranke Kinder
- Hilfe für krebskranke Kinder Frankfurt
- European Commission
- Deutsche Forschungsgemeinschaft (ERC StG 803565, MU 4216/1-1, CRC 1177)
- Aventis Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- SARS-CoV-2, COVID-19 pandemic, viral replication, host-pathogen interaction, translation (biology), splicing, carbon metabolism, proteostasis, nucleic acid metabolism, small molecule inhibitors, antiviral drug targets, proteome, translatome
- MeSH terms
- Betacoronavirus, Proteostasis, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Carbon, Drug Evaluation, Preclinical, Humans, Kinetics, Pneumonia, Viral, RNA Splicing, Time Factors, Protein Biosynthesis, Virus Replication, Coronavirus Infections, Caco-2 Cells, Proteome, Proteomics, Host-Pathogen Interactions, Pandemics, Molecular Targeted Therapy, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
